These data indicate that endocytosis, inflammation and axonal function are compromised in the early stages of PD, prior to the presence of local alpha-synuclein pathology in the SN [5, 6], whereas EIF2 and mTOR signaling is deregulated on mRNA expression level throughout disease progression in PD. The gene discussed is SNCA; the disease is Parkinson disease.